Merck to share molnupiravir formula with poor countries, enters agreement with MPP Ruchika Sharma28 Oct 2021 5:23 PM ISTGeneva: To ensure the affordable global access for molnupiravir, pharma giant Merck (MSD) has entered into a voluntary licencing...
Merck COVID-19 drug sparks calls for access for lower income countries Ruchika Sharma18 Oct 2021 3:38 PM ISTNew Delhi: The plan to roll out Merck & Co's promising antiviral pill to treat COVID-19 risks repeating the inequities of vaccine distribution,...
Will ask experts to scrutinize Merck Covid-19 pill in late November: FDA Ruchika Sharma16 Oct 2021 1:05 PM ISTWashington: The Food and Drug Administration said Thursday it will ask its outside experts to meet in late November to scrutinize Merck's pill to...
Everest Organics begins making API for Merck Molnupiravir Ruchika Sharma13 Oct 2021 3:13 PM ISTNew Delhi: India's Everest Organics Ltd said on Tuesday it had started making the active pharmaceutical ingredient (API) for a generic version of...
CDSCO panel rejects IQVIA proposed study of Proxalutamide in COVID patients Medical Dialogues Team12 Oct 2021 6:22 PM ISTNew Delhi: Rejecting IQVIA's proposed study, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) has denied...
Merck seeks USFDA authorization for anti-COVID pill Molnupiravir Ruchika Sharma12 Oct 2021 1:06 PM ISTNew Delhi: Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an entirely new and easy-to-use...
Maha: Woman doctor trying to order Covid-19 drug Actemra cheated of Rs 50000 Revu suresh10 Oct 2021 9:30 AM ISTMumbai: A woman doctor attached to a multi-specialty hospital in Charni Road, Mumbai was cheated of Rs 50000 while trying to place an order for...
Aurobindo Pharma, MSN seek CDSCO panel nod to cease Molnupiravir trial on moderate COVID patients Medical Dialogues Team9 Oct 2021 5:33 PM ISTNew Delhi: Seeking approval to end the study of Merck & Co's experimental antiviral drug Molnupiravir in moderate Covid-19 patients, two Indian...
Cipla eyes acquisitions after Covid windfall: Bloomberg Ruchika Sharma2 Oct 2021 9:30 AM ISTNew Delhi: Cipla Ltd., one of India's largest drugmakers, has built up a war chest and is on the prowl for deals that can boost growth beyond the...
Reduced GST rates on COVID drugs extended till December Ruchika Sharma18 Sept 2021 5:44 PM ISTLucknow: The GST Council on Friday extended concessional tax rates on COVID-19 medicines, cut tax on cancer drugs and waived GST on import of highly...
Bajaj Healthcare launches COVID drug under brand name DGJAJ Ruchika Sharma6 Sept 2021 11:45 AM ISTThe drug comes in powder form in a sachet, which is taken orally by dissolving it in water.
Pfizer, Merck launch new trials of oral antiviral drugs for COVID Ruchika Sharma4 Sept 2021 11:00 AM ISTNew Delhi: Pfizer Inc and Merck & Co Inc announced on Wednesday new trials of their experimental oral antiviral drugs for COVID-19 as...
